MINI FUTURE LONG - BOSTON SCIENTIFIC | Market Closed - Bid/Ask 01:17:37 28/06/2024 am IST | Pre-market 11:30:40 am | |||
| 4.62 EUR | -0.65% |
|
4.645 | +0.54% |
| 1 month | +2.67% | ||
| 3 months | +20.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 4.62 | -0.65% |
| 26/24/26 | 4.65 | 0.00% |
| 25/24/25 | 4.65 | +1.31% |
| 24/24/24 | 4.59 | -2.13% |
| 21/24/21 | 4.69 | +1.52% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 01:17 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | Morgan Stanley |
| WKN | MD6Y27 |
| ISIN | DE000MD6Y272 |
| Date issued | 09/08/2022 |
| Strike | 27.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.77 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.69 € |
|---|---|
| Lowest since issue | 1.5 € |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
77
USD
Average target price
82.35
USD
Spread / Average Target
+6.95%
- Stock Market
- Certificates
- Certificat
